| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Autoimmunity | 88 | 2026 | 933 | 11.880 |
Why?
|
| Islets of Langerhans | 65 | 2026 | 846 | 9.740 |
Why?
|
| Diabetes Mellitus, Type 1 | 131 | 2026 | 3922 | 8.880 |
Why?
|
| Autoantibodies | 103 | 2026 | 1509 | 7.290 |
Why?
|
| Arthritis, Rheumatoid | 51 | 2025 | 1180 | 6.310 |
Why?
|
| Vitamin D | 25 | 2026 | 403 | 4.610 |
Why?
|
| Diet | 33 | 2026 | 1277 | 4.040 |
Why?
|
| Genetic Predisposition to Disease | 76 | 2026 | 2378 | 3.520 |
Why?
|
| Rheumatoid Factor | 23 | 2025 | 178 | 3.500 |
Why?
|
| DNA Methylation | 10 | 2026 | 674 | 3.470 |
Why?
|
| Celiac Disease | 24 | 2026 | 311 | 3.450 |
Why?
|
| Anti-Citrullinated Protein Antibodies | 15 | 2025 | 127 | 3.420 |
Why?
|
| Fatty Acids, Omega-3 | 13 | 2020 | 143 | 3.330 |
Why?
|
| Lupus Erythematosus, Systemic | 10 | 2025 | 238 | 2.720 |
Why?
|
| Polymorphism, Single Nucleotide | 66 | 2026 | 2158 | 2.400 |
Why?
|
| Risk Factors | 114 | 2026 | 10885 | 2.320 |
Why?
|
| Child, Preschool | 115 | 2026 | 11853 | 2.280 |
Why?
|
| Glutens | 11 | 2023 | 59 | 2.250 |
Why?
|
| Genome-Wide Association Study | 33 | 2025 | 1407 | 2.120 |
Why?
|
| Disease Progression | 32 | 2026 | 2864 | 2.040 |
Why?
|
| Peptides, Cyclic | 21 | 2023 | 273 | 2.020 |
Why?
|
| Female | 293 | 2026 | 78844 | 2.000 |
Why?
|
| Erythrocyte Membrane | 6 | 2015 | 55 | 1.990 |
Why?
|
| Male | 277 | 2026 | 72842 | 1.980 |
Why?
|
| Infant | 109 | 2026 | 10077 | 1.970 |
Why?
|
| Child | 131 | 2026 | 22707 | 1.920 |
Why?
|
| Insulin Resistance | 46 | 2023 | 1244 | 1.840 |
Why?
|
| Prospective Studies | 74 | 2026 | 8057 | 1.830 |
Why?
|
| Humans | 375 | 2026 | 145474 | 1.790 |
Why?
|
| Breast Feeding | 22 | 2021 | 446 | 1.770 |
Why?
|
| Diabetes Mellitus, Type 2 | 39 | 2025 | 2588 | 1.650 |
Why?
|
| Adiposity | 21 | 2017 | 532 | 1.580 |
Why?
|
| Genotype | 54 | 2026 | 1852 | 1.570 |
Why?
|
| Vitamin D Deficiency | 7 | 2018 | 190 | 1.470 |
Why?
|
| Family | 23 | 2023 | 682 | 1.460 |
Why?
|
| Oxylipins | 3 | 2023 | 47 | 1.450 |
Why?
|
| HLA Antigens | 15 | 2026 | 240 | 1.390 |
Why?
|
| Milk | 12 | 2018 | 119 | 1.380 |
Why?
|
| Case-Control Studies | 43 | 2026 | 3623 | 1.350 |
Why?
|
| Infant Nutritional Physiological Phenomena | 8 | 2021 | 159 | 1.300 |
Why?
|
| Infant Food | 9 | 2018 | 69 | 1.240 |
Why?
|
| HLA-DR Antigens | 16 | 2024 | 220 | 1.240 |
Why?
|
| Cohort Studies | 56 | 2026 | 6013 | 1.230 |
Why?
|
| Follow-Up Studies | 46 | 2026 | 5423 | 1.210 |
Why?
|
| Middle Aged | 126 | 2025 | 36215 | 1.130 |
Why?
|
| Atherosclerosis | 19 | 2023 | 409 | 1.120 |
Why?
|
| Fatty Acids, Unsaturated | 3 | 2021 | 96 | 1.100 |
Why?
|
| Adiponectin | 11 | 2018 | 241 | 1.090 |
Why?
|
| Longitudinal Studies | 25 | 2026 | 2953 | 1.080 |
Why?
|
| Dietary Proteins | 7 | 2019 | 135 | 1.080 |
Why?
|
| Proportional Hazards Models | 20 | 2024 | 1327 | 1.080 |
Why?
|
| Adult | 135 | 2026 | 40777 | 1.070 |
Why?
|
| Body Mass Index | 33 | 2025 | 2445 | 1.070 |
Why?
|
| Prenatal Exposure Delayed Effects | 9 | 2025 | 652 | 1.060 |
Why?
|
| Seroconversion | 3 | 2026 | 48 | 1.050 |
Why?
|
| Insulin | 30 | 2021 | 2512 | 1.040 |
Why?
|
| Eating | 6 | 2023 | 387 | 1.030 |
Why?
|
| Biomarkers | 29 | 2026 | 4295 | 1.020 |
Why?
|
| HLA-DR4 Antigen | 11 | 2021 | 74 | 1.020 |
Why?
|
| Adolescent | 73 | 2026 | 22529 | 1.010 |
Why?
|
| Dietary Sucrose | 2 | 2020 | 50 | 0.950 |
Why?
|
| Smoking | 10 | 2025 | 1472 | 0.920 |
Why?
|
| Colorado | 39 | 2026 | 4553 | 0.890 |
Why?
|
| Micronutrients | 6 | 2026 | 102 | 0.870 |
Why?
|
| Infant, Newborn | 52 | 2026 | 6447 | 0.870 |
Why?
|
| Incidence | 23 | 2026 | 2923 | 0.860 |
Why?
|
| Obesity | 23 | 2025 | 3116 | 0.860 |
Why?
|
| Surveys and Questionnaires | 25 | 2024 | 6066 | 0.850 |
Why?
|
| Bacteroidaceae Infections | 4 | 2012 | 9 | 0.840 |
Why?
|
| Transglutaminases | 15 | 2026 | 159 | 0.830 |
Why?
|
| Environmental Exposure | 6 | 2025 | 578 | 0.780 |
Why?
|
| Cat Diseases | 6 | 2011 | 27 | 0.760 |
Why?
|
| Metabolic Syndrome | 6 | 2021 | 360 | 0.750 |
Why?
|
| Edible Grain | 5 | 2013 | 47 | 0.750 |
Why?
|
| Docosahexaenoic Acids | 5 | 2021 | 88 | 0.740 |
Why?
|
| Ascorbic Acid | 6 | 2026 | 184 | 0.740 |
Why?
|
| Antibodies, Bacterial | 5 | 2025 | 147 | 0.740 |
Why?
|
| Infant Formula | 5 | 2019 | 71 | 0.730 |
Why?
|
| Porphyromonas gingivalis | 4 | 2012 | 23 | 0.720 |
Why?
|
| Blood Glucose | 19 | 2021 | 2341 | 0.710 |
Why?
|
| Genetic Loci | 9 | 2025 | 264 | 0.710 |
Why?
|
| Child Nutritional Physiological Phenomena | 4 | 2019 | 106 | 0.700 |
Why?
|
| HLA-DR3 Antigen | 9 | 2023 | 76 | 0.700 |
Why?
|
| Mass Screening | 10 | 2024 | 1360 | 0.700 |
Why?
|
| Carnitine O-Palmitoyltransferase | 1 | 2021 | 49 | 0.680 |
Why?
|
| Epigenesis, Genetic | 7 | 2026 | 679 | 0.680 |
Why?
|
| Pregnancy | 31 | 2025 | 7202 | 0.680 |
Why?
|
| Epitopes | 5 | 2022 | 473 | 0.670 |
Why?
|
| Mexican Americans | 6 | 2024 | 119 | 0.660 |
Why?
|
| Periodontitis | 3 | 2012 | 55 | 0.660 |
Why?
|
| Autoimmune Diseases | 8 | 2019 | 468 | 0.660 |
Why?
|
| F2-Isoprostanes | 2 | 2015 | 20 | 0.650 |
Why?
|
| HLA-DQ Antigens | 14 | 2018 | 174 | 0.640 |
Why?
|
| Fatty Acids, Omega-6 | 5 | 2020 | 47 | 0.630 |
Why?
|
| Maternal Nutritional Physiological Phenomena | 7 | 2021 | 178 | 0.630 |
Why?
|
| Age Factors | 27 | 2024 | 3342 | 0.630 |
Why?
|
| Inflammation Mediators | 4 | 2020 | 506 | 0.620 |
Why?
|
| Sugars | 1 | 2020 | 40 | 0.620 |
Why?
|
| Receptors, Calcitriol | 4 | 2016 | 55 | 0.620 |
Why?
|
| Metabolomics | 5 | 2023 | 732 | 0.610 |
Why?
|
| Phenotype | 30 | 2025 | 3155 | 0.610 |
Why?
|
| Dietary Supplements | 9 | 2024 | 583 | 0.600 |
Why?
|
| Overweight | 6 | 2021 | 614 | 0.600 |
Why?
|
| Phospholipids | 1 | 2021 | 214 | 0.600 |
Why?
|
| Gene Frequency | 17 | 2021 | 487 | 0.590 |
Why?
|
| Immunoglobulin A | 10 | 2024 | 214 | 0.590 |
Why?
|
| Genetic Variation | 9 | 2017 | 972 | 0.590 |
Why?
|
| Genome, Human | 9 | 2021 | 420 | 0.590 |
Why?
|
| Aged | 56 | 2025 | 26153 | 0.580 |
Why?
|
| Alleles | 15 | 2021 | 894 | 0.570 |
Why?
|
| Polymorphism, Genetic | 11 | 2021 | 614 | 0.560 |
Why?
|
| Immunoglobulin G | 8 | 2023 | 892 | 0.560 |
Why?
|
| Family Health | 12 | 2017 | 191 | 0.560 |
Why?
|
| Milk Proteins | 3 | 2008 | 33 | 0.550 |
Why?
|
| Hypertension, Pregnancy-Induced | 1 | 2018 | 69 | 0.530 |
Why?
|
| Glutamate Decarboxylase | 12 | 2021 | 165 | 0.520 |
Why?
|
| Genetic Linkage | 11 | 2016 | 272 | 0.520 |
Why?
|
| Sleep | 3 | 2025 | 888 | 0.510 |
Why?
|
| PPAR gamma | 3 | 2016 | 178 | 0.500 |
Why?
|
| GTP-Binding Proteins | 7 | 2026 | 153 | 0.490 |
Why?
|
| Feline Acquired Immunodeficiency Syndrome | 1 | 2016 | 2 | 0.490 |
Why?
|
| Quantitative Trait, Heritable | 3 | 2021 | 113 | 0.490 |
Why?
|
| Cytokines | 7 | 2020 | 2067 | 0.490 |
Why?
|
| Vitamin D3 24-Hydroxylase | 1 | 2016 | 16 | 0.480 |
Why?
|
| Arachidonic Acid | 2 | 2021 | 102 | 0.480 |
Why?
|
| Dietary Carbohydrates | 2 | 2015 | 147 | 0.480 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 22 | 8 | 2019 | 48 | 0.480 |
Why?
|
| Multivariate Analysis | 13 | 2021 | 1547 | 0.470 |
Why?
|
| Intra-Abdominal Fat | 11 | 2021 | 101 | 0.470 |
Why?
|
| Population Surveillance | 5 | 2015 | 484 | 0.470 |
Why?
|
| Non-alcoholic Fatty Liver Disease | 6 | 2023 | 265 | 0.470 |
Why?
|
| Sputum | 4 | 2021 | 302 | 0.470 |
Why?
|
| Diet Surveys | 7 | 2021 | 90 | 0.470 |
Why?
|
| Carbohydrates | 2 | 2015 | 66 | 0.470 |
Why?
|
| Diabetes, Gestational | 7 | 2020 | 306 | 0.460 |
Why?
|
| CpG Islands | 4 | 2025 | 163 | 0.460 |
Why?
|
| Homeostasis | 15 | 2023 | 642 | 0.450 |
Why?
|
| Feeding Methods | 1 | 2015 | 5 | 0.450 |
Why?
|
| Air Pollution | 2 | 2024 | 314 | 0.450 |
Why?
|
| Vitamin A | 2 | 2026 | 60 | 0.450 |
Why?
|
| B-Lymphocytes | 3 | 2026 | 870 | 0.450 |
Why?
|
| Viral Vaccines | 1 | 2016 | 107 | 0.440 |
Why?
|
| Child Day Care Centers | 1 | 2015 | 44 | 0.440 |
Why?
|
| Interprofessional Relations | 1 | 2017 | 275 | 0.430 |
Why?
|
| Feeding Behavior | 4 | 2018 | 690 | 0.430 |
Why?
|
| Young Adult | 28 | 2026 | 14218 | 0.420 |
Why?
|
| Chemokines | 2 | 2012 | 217 | 0.420 |
Why?
|
| Cooperative Behavior | 1 | 2017 | 462 | 0.420 |
Why?
|
| Pedigree | 12 | 2020 | 515 | 0.410 |
Why?
|
| Tobacco Smoke Pollution | 3 | 2007 | 227 | 0.410 |
Why?
|
| Altitude | 1 | 2018 | 463 | 0.410 |
Why?
|
| Alberta | 4 | 2022 | 25 | 0.410 |
Why?
|
| Dietary Fats, Unsaturated | 3 | 2011 | 24 | 0.400 |
Why?
|
| Glucose | 11 | 2023 | 1048 | 0.400 |
Why?
|
| Joints | 3 | 2013 | 106 | 0.400 |
Why?
|
| Blood Pressure | 8 | 2020 | 1779 | 0.400 |
Why?
|
| Diet Records | 5 | 2019 | 89 | 0.400 |
Why?
|
| United States | 45 | 2025 | 16098 | 0.390 |
Why?
|
| Fatty Acid Desaturases | 1 | 2013 | 31 | 0.390 |
Why?
|
| Cholesterol, HDL | 6 | 2025 | 201 | 0.390 |
Why?
|
| Quantitative Trait Loci | 10 | 2025 | 378 | 0.390 |
Why?
|
| Dietary Fats | 3 | 2011 | 308 | 0.390 |
Why?
|
| Energy Intake | 7 | 2023 | 512 | 0.390 |
Why?
|
| Age of Onset | 10 | 2026 | 555 | 0.390 |
Why?
|
| Social Responsibility | 1 | 2013 | 53 | 0.390 |
Why?
|
| Dog Diseases | 3 | 2025 | 86 | 0.390 |
Why?
|
| Triglycerides | 7 | 2025 | 520 | 0.390 |
Why?
|
| Genetic Association Studies | 7 | 2020 | 369 | 0.390 |
Why?
|
| Lipids | 7 | 2025 | 707 | 0.390 |
Why?
|
| Pregnancy in Diabetics | 4 | 2012 | 123 | 0.380 |
Why?
|
| Genetic Testing | 9 | 2020 | 480 | 0.380 |
Why?
|
| Psychometrics | 2 | 2017 | 731 | 0.380 |
Why?
|
| Probiotics | 3 | 2019 | 61 | 0.380 |
Why?
|
| Stress, Psychological | 2 | 2020 | 1146 | 0.380 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 2 | 1 | 2012 | 13 | 0.370 |
Why?
|
| Pediatrics | 2 | 2020 | 1121 | 0.370 |
Why?
|
| Vaccination | 2 | 2022 | 1426 | 0.360 |
Why?
|
| C-Reactive Protein | 6 | 2018 | 422 | 0.360 |
Why?
|
| Fluorocarbons | 2 | 2023 | 120 | 0.360 |
Why?
|
| Nurse's Role | 1 | 2013 | 149 | 0.350 |
Why?
|
| Europe | 13 | 2020 | 418 | 0.350 |
Why?
|
| Membrane Proteins | 8 | 2025 | 1164 | 0.350 |
Why?
|
| Risk Assessment | 13 | 2020 | 3747 | 0.350 |
Why?
|
| Exome | 4 | 2021 | 227 | 0.350 |
Why?
|
| Calcifediol | 1 | 2011 | 31 | 0.340 |
Why?
|
| Texas | 9 | 2014 | 272 | 0.340 |
Why?
|
| Nursing Staff, Hospital | 1 | 2013 | 143 | 0.340 |
Why?
|
| Workplace | 1 | 2013 | 272 | 0.340 |
Why?
|
| Cross-Sectional Studies | 12 | 2022 | 5904 | 0.340 |
Why?
|
| Nutritional Status | 3 | 2013 | 353 | 0.330 |
Why?
|
| RGS Proteins | 1 | 2011 | 17 | 0.330 |
Why?
|
| Waist-Hip Ratio | 3 | 2007 | 37 | 0.330 |
Why?
|
| Extracellular Traps | 3 | 2021 | 52 | 0.330 |
Why?
|
| Logistic Models | 10 | 2019 | 2134 | 0.330 |
Why?
|
| Food, Fortified | 1 | 2010 | 44 | 0.320 |
Why?
|
| Cats | 8 | 2016 | 231 | 0.320 |
Why?
|
| Fetal Blood | 5 | 2021 | 327 | 0.320 |
Why?
|
| Porphyromonas | 2 | 2001 | 3 | 0.320 |
Why?
|
| Delivery of Health Care | 1 | 2017 | 946 | 0.310 |
Why?
|
| Prognosis | 11 | 2026 | 4316 | 0.310 |
Why?
|
| Antigens, Bacterial | 2 | 2001 | 126 | 0.300 |
Why?
|
| Animals | 36 | 2025 | 38030 | 0.300 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 7 | 2019 | 848 | 0.300 |
Why?
|
| Carotenoids | 2 | 2026 | 47 | 0.300 |
Why?
|
| Food Preferences | 1 | 2011 | 126 | 0.300 |
Why?
|
| Models, Genetic | 6 | 2017 | 524 | 0.300 |
Why?
|
| Periodontal Diseases | 2 | 2001 | 62 | 0.300 |
Why?
|
| Diabetes Mellitus | 6 | 2020 | 1097 | 0.300 |
Why?
|
| HLA-DQ beta-Chains | 7 | 2015 | 58 | 0.290 |
Why?
|
| Exercise | 5 | 2022 | 2198 | 0.290 |
Why?
|
| Body Height | 2 | 2009 | 202 | 0.290 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 4 | 2021 | 749 | 0.280 |
Why?
|
| Th17 Cells | 3 | 2025 | 101 | 0.280 |
Why?
|
| Insulin-Secreting Cells | 5 | 2018 | 392 | 0.280 |
Why?
|
| Adipose Tissue | 8 | 2017 | 645 | 0.280 |
Why?
|
| Air Pollutants | 2 | 2024 | 405 | 0.280 |
Why?
|
| Prenatal Nutritional Physiological Phenomena | 3 | 2017 | 55 | 0.280 |
Why?
|
| Glycemic Index | 1 | 2008 | 26 | 0.280 |
Why?
|
| Quality Improvement | 1 | 2017 | 1295 | 0.280 |
Why?
|
| Life Style | 5 | 2015 | 485 | 0.280 |
Why?
|
| Vaccines | 2 | 2023 | 388 | 0.270 |
Why?
|
| Calcitriol | 1 | 2008 | 57 | 0.270 |
Why?
|
| Seizures | 2 | 2006 | 483 | 0.270 |
Why?
|
| Vitamins | 3 | 2024 | 182 | 0.270 |
Why?
|
| Odds Ratio | 7 | 2019 | 1082 | 0.260 |
Why?
|
| Seroepidemiologic Studies | 5 | 2025 | 171 | 0.260 |
Why?
|
| Environmental Pollutants | 2 | 2024 | 139 | 0.260 |
Why?
|
| Regression Analysis | 9 | 2017 | 1001 | 0.260 |
Why?
|
| Linear Models | 4 | 2019 | 845 | 0.260 |
Why?
|
| Inflammation | 5 | 2022 | 2878 | 0.260 |
Why?
|
| Sex Factors | 12 | 2019 | 2105 | 0.260 |
Why?
|
| Psychology, Child | 1 | 2007 | 36 | 0.250 |
Why?
|
| Bias | 3 | 2021 | 197 | 0.250 |
Why?
|
| Fetal Distress | 1 | 2006 | 14 | 0.250 |
Why?
|
| Lipid Metabolism | 3 | 2019 | 529 | 0.240 |
Why?
|
| Lipase | 3 | 2019 | 75 | 0.240 |
Why?
|
| Linkage Disequilibrium | 5 | 2011 | 253 | 0.240 |
Why?
|
| Wheat Hypersensitivity | 1 | 2006 | 4 | 0.240 |
Why?
|
| Reproducibility of Results | 10 | 2018 | 3413 | 0.240 |
Why?
|
| Contraceptives, Oral, Hormonal | 1 | 2006 | 30 | 0.240 |
Why?
|
| Tocopherols | 1 | 2026 | 31 | 0.240 |
Why?
|
| Heat-Shock Proteins | 1 | 2007 | 139 | 0.240 |
Why?
|
| Immunoglobulin M | 5 | 2022 | 265 | 0.240 |
Why?
|
| Immunophenotyping | 2 | 2025 | 319 | 0.240 |
Why?
|
| Insulin Antibodies | 6 | 2016 | 103 | 0.240 |
Why?
|
| Abdominal Fat | 6 | 2017 | 51 | 0.240 |
Why?
|
| Vitamin D-Binding Protein | 3 | 2021 | 16 | 0.230 |
Why?
|
| Precision Medicine | 2 | 2020 | 459 | 0.230 |
Why?
|
| Pregnancy Complications, Cardiovascular | 1 | 2006 | 85 | 0.230 |
Why?
|
| Tumor Necrosis Factor-alpha | 3 | 2021 | 1217 | 0.230 |
Why?
|
| Genetic Markers | 6 | 2013 | 335 | 0.230 |
Why?
|
| C-Peptide | 4 | 2017 | 190 | 0.230 |
Why?
|
| Cattle | 7 | 2017 | 946 | 0.230 |
Why?
|
| Protective Factors | 2 | 2016 | 99 | 0.230 |
Why?
|
| Risk | 8 | 2019 | 919 | 0.230 |
Why?
|
| Autoantigens | 5 | 2021 | 427 | 0.220 |
Why?
|
| Dyslipidemias | 2 | 2025 | 184 | 0.220 |
Why?
|
| Birth Weight | 4 | 2018 | 514 | 0.220 |
Why?
|
| Electroconvulsive Therapy | 2 | 1996 | 16 | 0.220 |
Why?
|
| Leptospira | 1 | 2025 | 4 | 0.220 |
Why?
|
| Leptospirosis | 1 | 2025 | 8 | 0.220 |
Why?
|
| Chromosome Mapping | 12 | 2009 | 506 | 0.220 |
Why?
|
| Infant, Newborn, Diseases | 1 | 2006 | 115 | 0.220 |
Why?
|
| beta Carotene | 1 | 2024 | 20 | 0.220 |
Why?
|
| Rubella | 2 | 2023 | 23 | 0.220 |
Why?
|
| Chlamydia trachomatis | 1 | 2025 | 49 | 0.210 |
Why?
|
| Time Factors | 17 | 2017 | 7123 | 0.210 |
Why?
|
| Chromosomes, Human, Pair 17 | 5 | 2008 | 54 | 0.210 |
Why?
|
| Hypertension | 5 | 2020 | 1273 | 0.210 |
Why?
|
| Glucose Tolerance Test | 10 | 2018 | 360 | 0.210 |
Why?
|
| Aged, 80 and over | 18 | 2019 | 8333 | 0.210 |
Why?
|
| Alanine Transaminase | 3 | 2021 | 151 | 0.210 |
Why?
|
| Disease Susceptibility | 4 | 2020 | 344 | 0.210 |
Why?
|
| Fatty Acids | 2 | 2021 | 457 | 0.210 |
Why?
|
| Body Composition | 5 | 2017 | 693 | 0.210 |
Why?
|
| Sweden | 6 | 2024 | 115 | 0.210 |
Why?
|
| Germany | 6 | 2024 | 138 | 0.200 |
Why?
|
| Fasting | 7 | 2015 | 279 | 0.200 |
Why?
|
| Chlamydia Infections | 1 | 2025 | 79 | 0.200 |
Why?
|
| Vitamin B Complex | 1 | 2024 | 39 | 0.200 |
Why?
|
| Bottle Feeding | 2 | 2018 | 19 | 0.200 |
Why?
|
| Australia | 5 | 2016 | 288 | 0.200 |
Why?
|
| Mumps | 1 | 2023 | 21 | 0.200 |
Why?
|
| Germ-Line Mutation | 1 | 2024 | 176 | 0.200 |
Why?
|
| Nerve Tissue Proteins | 3 | 2023 | 591 | 0.200 |
Why?
|
| Arteriosclerosis | 6 | 2005 | 83 | 0.200 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 1 | 2024 | 132 | 0.200 |
Why?
|
| Data Accuracy | 1 | 2024 | 65 | 0.200 |
Why?
|
| Measles | 1 | 2023 | 46 | 0.190 |
Why?
|
| Nuclear Family | 5 | 2019 | 50 | 0.190 |
Why?
|
| GTPase-Activating Proteins | 1 | 2023 | 81 | 0.190 |
Why?
|
| Iron Overload | 1 | 2023 | 19 | 0.190 |
Why?
|
| Interleukin-6 | 2 | 2021 | 776 | 0.190 |
Why?
|
| 25-Hydroxyvitamin D3 1-alpha-Hydroxylase | 2 | 2016 | 18 | 0.190 |
Why?
|
| Chickenpox | 1 | 2023 | 84 | 0.190 |
Why?
|
| Protein-Arginine Deiminases | 3 | 2021 | 15 | 0.190 |
Why?
|
| Erythrocytes | 2 | 2021 | 748 | 0.190 |
Why?
|
| Intestinal Mucosa | 1 | 2008 | 675 | 0.190 |
Why?
|
| Prevalence | 6 | 2017 | 2865 | 0.180 |
Why?
|
| Mucous Membrane | 2 | 2024 | 128 | 0.180 |
Why?
|
| Finland | 5 | 2024 | 78 | 0.180 |
Why?
|
| Receptor-Like Protein Tyrosine Phosphatases, Class 8 | 2 | 2021 | 54 | 0.180 |
Why?
|
| Citrullination | 2 | 2020 | 12 | 0.180 |
Why?
|
| Pediatric Obesity | 3 | 2018 | 638 | 0.180 |
Why?
|
| Cotinine | 1 | 2002 | 77 | 0.180 |
Why?
|
| Urine | 1 | 2002 | 64 | 0.180 |
Why?
|
| Transcription Factors | 3 | 2019 | 1734 | 0.170 |
Why?
|
| Aspartate Aminotransferases | 2 | 2019 | 85 | 0.170 |
Why?
|
| Sleep Wake Disorders | 1 | 2025 | 314 | 0.170 |
Why?
|
| Sulfates | 1 | 2021 | 45 | 0.170 |
Why?
|
| Citrulline | 2 | 2016 | 45 | 0.170 |
Why?
|
| Bacteroides Infections | 1 | 2001 | 2 | 0.170 |
Why?
|
| Hydroxyeicosatetraenoic Acids | 1 | 2021 | 35 | 0.170 |
Why?
|
| Liver Glycogen | 1 | 2021 | 16 | 0.170 |
Why?
|
| Lactones | 1 | 2021 | 59 | 0.170 |
Why?
|
| Linoleic Acid | 1 | 2021 | 44 | 0.170 |
Why?
|
| Apolipoproteins E | 1 | 2021 | 93 | 0.170 |
Why?
|
| Sunlight | 1 | 2001 | 78 | 0.170 |
Why?
|
| Lymphocyte Activation | 1 | 2025 | 1132 | 0.170 |
Why?
|
| Arthralgia | 1 | 2021 | 61 | 0.160 |
Why?
|
| Protein Phosphatase 1 | 1 | 2021 | 32 | 0.160 |
Why?
|
| Neutrophils | 2 | 2026 | 1124 | 0.160 |
Why?
|
| Glycogen Storage Disease | 1 | 2021 | 19 | 0.160 |
Why?
|
| Lod Score | 7 | 2017 | 62 | 0.160 |
Why?
|
| Propensity Score | 1 | 2023 | 377 | 0.160 |
Why?
|
| CD8-Positive T-Lymphocytes | 2 | 2025 | 919 | 0.160 |
Why?
|
| Fluoroquinolones | 2 | 2011 | 44 | 0.160 |
Why?
|
| Tandem Mass Spectrometry | 2 | 2021 | 572 | 0.160 |
Why?
|
| Health Status | 2 | 2023 | 832 | 0.160 |
Why?
|
| Antibodies, Viral | 3 | 2019 | 674 | 0.160 |
Why?
|
| Origin of Life | 1 | 2020 | 8 | 0.160 |
Why?
|
| Tumor Necrosis Factor Ligand Superfamily Member 15 | 1 | 2020 | 8 | 0.160 |
Why?
|
| Iodide Peroxidase | 1 | 2020 | 35 | 0.160 |
Why?
|
| Specimen Handling | 1 | 2002 | 182 | 0.160 |
Why?
|
| Isotopes | 1 | 2020 | 33 | 0.160 |
Why?
|
| Prediabetic State | 3 | 2012 | 249 | 0.160 |
Why?
|
| Fatty Liver | 3 | 2013 | 253 | 0.160 |
Why?
|
| Interleukin-8 | 1 | 2021 | 269 | 0.150 |
Why?
|
| Father-Child Relations | 1 | 2019 | 8 | 0.150 |
Why?
|
| Gastroenteritis | 2 | 2019 | 63 | 0.150 |
Why?
|
| Peroxidase | 1 | 2020 | 168 | 0.150 |
Why?
|
| Endopeptidases | 1 | 2000 | 80 | 0.150 |
Why?
|
| Mycobacterium | 2 | 2011 | 101 | 0.150 |
Why?
|
| Survival Analysis | 4 | 2017 | 1374 | 0.150 |
Why?
|
| Registries | 9 | 2019 | 2406 | 0.150 |
Why?
|
| Toll-Like Receptors | 1 | 2020 | 193 | 0.150 |
Why?
|
| Mental Recall | 4 | 2017 | 222 | 0.150 |
Why?
|
| Metabolic Clearance Rate | 3 | 2014 | 115 | 0.150 |
Why?
|
| Dogs | 6 | 2025 | 458 | 0.150 |
Why?
|
| Threonine | 1 | 1999 | 44 | 0.150 |
Why?
|
| Endocrinology | 1 | 2020 | 77 | 0.150 |
Why?
|
| Antigens, Viral | 2 | 2019 | 182 | 0.150 |
Why?
|
| Gingiva | 1 | 1999 | 25 | 0.150 |
Why?
|
| Self Report | 2 | 2022 | 870 | 0.150 |
Why?
|
| HLA-D Antigens | 2 | 2017 | 30 | 0.150 |
Why?
|
| Transcription Factor 7-Like 2 Protein | 2 | 2017 | 26 | 0.140 |
Why?
|
| Interleukin-1beta | 1 | 2021 | 389 | 0.140 |
Why?
|
| Iron | 2 | 2023 | 357 | 0.140 |
Why?
|
| Parents | 2 | 2007 | 1403 | 0.140 |
Why?
|
| Gas Chromatography-Mass Spectrometry | 1 | 1999 | 124 | 0.140 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2021 | 592 | 0.140 |
Why?
|
| Meta-Analysis as Topic | 1 | 2019 | 171 | 0.140 |
Why?
|
| Health | 2 | 2013 | 82 | 0.140 |
Why?
|
| Subcutaneous Fat | 5 | 2010 | 79 | 0.140 |
Why?
|
| Leukocytes, Mononuclear | 2 | 2024 | 574 | 0.140 |
Why?
|
| Plasminogen Activator Inhibitor 1 | 2 | 2012 | 85 | 0.140 |
Why?
|
| Arthritis, Experimental | 1 | 2020 | 136 | 0.140 |
Why?
|
| Histones | 2 | 2021 | 666 | 0.140 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2025 | 1140 | 0.140 |
Why?
|
| Antibodies | 3 | 2011 | 397 | 0.140 |
Why?
|
| Interleukins | 1 | 2020 | 248 | 0.140 |
Why?
|
| Herpesvirus 4, Human | 1 | 2019 | 172 | 0.140 |
Why?
|
| Hypersensitivity | 1 | 2021 | 254 | 0.140 |
Why?
|
| Consensus | 1 | 2020 | 477 | 0.140 |
Why?
|
| Adaptor Proteins, Signal Transducing | 4 | 2013 | 425 | 0.140 |
Why?
|
| Collagen | 2 | 2020 | 457 | 0.140 |
Why?
|
| Child Health | 1 | 2019 | 153 | 0.130 |
Why?
|
| Herpesviridae Infections | 1 | 2019 | 148 | 0.130 |
Why?
|
| Emergency Nursing | 1 | 2017 | 22 | 0.130 |
Why?
|
| Leadership | 1 | 2022 | 401 | 0.130 |
Why?
|
| Monocytes | 1 | 2020 | 539 | 0.130 |
Why?
|
| Sensitivity and Specificity | 5 | 2015 | 1997 | 0.130 |
Why?
|
| Enterovirus Infections | 3 | 2010 | 173 | 0.130 |
Why?
|
| Chromatography, Liquid | 1 | 2019 | 450 | 0.130 |
Why?
|
| Allied Health Personnel | 1 | 2017 | 53 | 0.130 |
Why?
|
| Niacin | 1 | 2017 | 16 | 0.130 |
Why?
|
| Gestational Age | 4 | 2020 | 987 | 0.130 |
Why?
|
| Maternal Age | 3 | 2004 | 128 | 0.130 |
Why?
|
| Acyltransferases | 4 | 2023 | 78 | 0.130 |
Why?
|
| Socioeconomic Factors | 6 | 2017 | 1323 | 0.130 |
Why?
|
| Bone Density | 1 | 2021 | 487 | 0.130 |
Why?
|
| Patient Handoff | 1 | 2017 | 44 | 0.130 |
Why?
|
| Severity of Illness Index | 4 | 2025 | 2930 | 0.130 |
Why?
|
| Pipecolic Acids | 1 | 1997 | 26 | 0.120 |
Why?
|
| Calcium | 1 | 2023 | 1190 | 0.120 |
Why?
|
| Neoplasm Proteins | 1 | 2020 | 441 | 0.120 |
Why?
|
| Mothers | 4 | 2018 | 765 | 0.120 |
Why?
|
| Eicosapentaenoic Acid | 2 | 2013 | 37 | 0.120 |
Why?
|
| NFI Transcription Factors | 1 | 2016 | 7 | 0.120 |
Why?
|
| Amino Acid Sequence | 7 | 2000 | 2129 | 0.120 |
Why?
|
| Excitatory Amino Acid Antagonists | 1 | 1997 | 108 | 0.120 |
Why?
|
| Oxidative Stress | 1 | 2003 | 1356 | 0.120 |
Why?
|
| Bacterial Proteins | 2 | 2001 | 967 | 0.120 |
Why?
|
| Hydrolases | 2 | 2021 | 40 | 0.120 |
Why?
|
| Laminin | 1 | 2016 | 72 | 0.120 |
Why?
|
| Immunity, Innate | 1 | 2022 | 835 | 0.120 |
Why?
|
| Myocardial Infarction | 2 | 2021 | 1210 | 0.120 |
Why?
|
| Research | 1 | 2019 | 430 | 0.120 |
Why?
|
| Patient Care Team | 1 | 2022 | 696 | 0.120 |
Why?
|
| Prenatal Care | 2 | 2017 | 309 | 0.120 |
Why?
|
| Plasma Cells | 1 | 2016 | 79 | 0.120 |
Why?
|
| Algorithms | 2 | 2023 | 1845 | 0.120 |
Why?
|
| Coxiella burnetii | 1 | 2016 | 2 | 0.120 |
Why?
|
| Respiratory Tract Infections | 2 | 2019 | 396 | 0.120 |
Why?
|
| Factor Analysis, Statistical | 1 | 2017 | 291 | 0.120 |
Why?
|
| Q Fever | 1 | 2016 | 5 | 0.120 |
Why?
|
| Prolactin | 1 | 1996 | 87 | 0.120 |
Why?
|
| Adipogenesis | 1 | 2016 | 56 | 0.120 |
Why?
|
| Umbilical Cord | 1 | 2016 | 93 | 0.120 |
Why?
|
| Complement System Proteins | 1 | 2019 | 314 | 0.120 |
Why?
|
| Cerebrovascular Disorders | 1 | 1997 | 104 | 0.120 |
Why?
|
| Databases, Factual | 3 | 2018 | 1490 | 0.120 |
Why?
|
| Diet, High-Fat | 1 | 2017 | 266 | 0.120 |
Why?
|
| Microsatellite Repeats | 2 | 2014 | 157 | 0.110 |
Why?
|
| Fatigue | 1 | 2018 | 364 | 0.110 |
Why?
|
| Tomography, X-Ray Computed | 9 | 2017 | 2769 | 0.110 |
Why?
|
| Haplotypes | 6 | 2008 | 499 | 0.110 |
Why?
|
| Environment | 3 | 2019 | 293 | 0.110 |
Why?
|
| Arthritis | 1 | 2016 | 96 | 0.110 |
Why?
|
| Retrospective Studies | 13 | 2022 | 17291 | 0.110 |
Why?
|
| Niacinamide | 1 | 2016 | 104 | 0.110 |
Why?
|
| Isocitrate Dehydrogenase | 1 | 2015 | 72 | 0.110 |
Why?
|
| Cardiovascular Diseases | 4 | 2021 | 2187 | 0.110 |
Why?
|
| Interleukin-2 | 2 | 2016 | 440 | 0.110 |
Why?
|
| Dietary Fiber | 1 | 2015 | 59 | 0.110 |
Why?
|
| Cholesterol, LDL | 3 | 2025 | 360 | 0.110 |
Why?
|
| Early Diagnosis | 4 | 2019 | 251 | 0.110 |
Why?
|
| Mutation Rate | 1 | 2015 | 33 | 0.110 |
Why?
|
| Hydrocarbons, Chlorinated | 1 | 2014 | 21 | 0.110 |
Why?
|
| Predictive Value of Tests | 9 | 2018 | 2121 | 0.110 |
Why?
|
| Patient Transfer | 1 | 2017 | 211 | 0.110 |
Why?
|
| Self Disclosure | 2 | 2007 | 61 | 0.110 |
Why?
|
| Gene-Environment Interaction | 4 | 2018 | 180 | 0.110 |
Why?
|
| Metabolome | 1 | 2018 | 388 | 0.110 |
Why?
|
| Quality of Life | 3 | 2024 | 3204 | 0.100 |
Why?
|
| Pesticides | 1 | 2014 | 59 | 0.100 |
Why?
|
| Minority Groups | 3 | 2011 | 284 | 0.100 |
Why?
|
| Serum Albumin, Bovine | 1 | 1994 | 62 | 0.100 |
Why?
|
| Siblings | 3 | 2010 | 196 | 0.100 |
Why?
|
| Asthma | 2 | 2023 | 1797 | 0.100 |
Why?
|
| Beverages | 1 | 2014 | 68 | 0.100 |
Why?
|
| Selenoprotein P | 1 | 2013 | 3 | 0.100 |
Why?
|
| Liver | 7 | 2023 | 1896 | 0.100 |
Why?
|
| Body Weight | 3 | 2017 | 971 | 0.100 |
Why?
|
| Dominance, Cerebral | 1 | 1993 | 56 | 0.100 |
Why?
|
| Models, Nursing | 1 | 2013 | 30 | 0.100 |
Why?
|
| Mental Health | 1 | 2020 | 793 | 0.100 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 2 | 2023 | 456 | 0.100 |
Why?
|
| Schizophrenic Psychology | 1 | 1993 | 96 | 0.100 |
Why?
|
| Immunoglobulins | 2 | 2015 | 162 | 0.100 |
Why?
|
| Geographic Information Systems | 1 | 2013 | 45 | 0.100 |
Why?
|
| Genes, MHC Class II | 1 | 2012 | 76 | 0.090 |
Why?
|
| Chromosomes, Human, Pair 3 | 3 | 2010 | 43 | 0.090 |
Why?
|
| Interleukin-9 | 1 | 2012 | 11 | 0.090 |
Why?
|
| Tuberculosis, Bovine | 1 | 2012 | 2 | 0.090 |
Why?
|
| Molecular Sequence Data | 6 | 2000 | 2883 | 0.090 |
Why?
|
| Cell Membrane | 1 | 2016 | 707 | 0.090 |
Why?
|
| Likelihood Functions | 4 | 2012 | 138 | 0.090 |
Why?
|
| Task Performance and Analysis | 1 | 2013 | 198 | 0.090 |
Why?
|
| Epistasis, Genetic | 3 | 2020 | 63 | 0.090 |
Why?
|
| Alpha-Ketoglutarate-Dependent Dioxygenase FTO | 3 | 2023 | 25 | 0.090 |
Why?
|
| Patient Compliance | 2 | 2015 | 587 | 0.090 |
Why?
|
| Bronchial Diseases | 1 | 2011 | 38 | 0.090 |
Why?
|
| Child of Impaired Parents | 1 | 2012 | 38 | 0.090 |
Why?
|
| Body Fat Distribution | 2 | 2013 | 46 | 0.090 |
Why?
|
| 25-Hydroxyvitamin D 2 | 1 | 2011 | 6 | 0.090 |
Why?
|
| Whole Genome Sequencing | 2 | 2024 | 177 | 0.090 |
Why?
|
| Fatty Acids, Nonesterified | 1 | 2012 | 154 | 0.090 |
Why?
|
| Clinical Trials as Topic | 1 | 1997 | 1061 | 0.090 |
Why?
|
| HLA-DRB1 Chains | 3 | 2012 | 110 | 0.090 |
Why?
|
| Nocardia | 1 | 2011 | 6 | 0.090 |
Why?
|
| Histocompatibility Testing | 3 | 2007 | 123 | 0.090 |
Why?
|
| Vegetables | 2 | 2013 | 161 | 0.090 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2012 | 161 | 0.080 |
Why?
|
| Nocardia Infections | 1 | 2011 | 11 | 0.080 |
Why?
|
| DNA Primers | 4 | 2007 | 505 | 0.080 |
Why?
|
| Phospholipases A2, Calcium-Independent | 3 | 2019 | 18 | 0.080 |
Why?
|
| Alcohol Drinking | 1 | 2018 | 837 | 0.080 |
Why?
|
| Mycobacterium Infections | 1 | 2011 | 55 | 0.080 |
Why?
|
| DNA | 4 | 2009 | 1435 | 0.080 |
Why?
|
| Chi-Square Distribution | 1 | 2012 | 527 | 0.080 |
Why?
|
| Triticum | 1 | 2010 | 18 | 0.080 |
Why?
|
| DNA Mutational Analysis | 3 | 2024 | 407 | 0.080 |
Why?
|
| Bipolar Disorder | 1 | 1993 | 282 | 0.080 |
Why?
|
| Depressive Disorder | 1 | 1993 | 374 | 0.080 |
Why?
|
| Mice | 6 | 2022 | 18329 | 0.080 |
Why?
|
| Environmental Monitoring | 1 | 2013 | 346 | 0.080 |
Why?
|
| Societies, Medical | 3 | 2020 | 899 | 0.080 |
Why?
|
| Peptide Fragments | 1 | 1994 | 693 | 0.080 |
Why?
|
| Insurance, Health | 3 | 1999 | 310 | 0.080 |
Why?
|
| Liver Cirrhosis | 2 | 2023 | 287 | 0.080 |
Why?
|
| Plant Proteins | 1 | 2011 | 111 | 0.080 |
Why?
|
| Particulate Matter | 1 | 2013 | 326 | 0.080 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 2 | 2001 | 331 | 0.080 |
Why?
|
| Electroencephalography | 1 | 1993 | 561 | 0.080 |
Why?
|
| Statistics, Nonparametric | 2 | 2010 | 428 | 0.080 |
Why?
|
| Diet, Gluten-Free | 2 | 2024 | 56 | 0.080 |
Why?
|
| Health Fairs | 1 | 2009 | 10 | 0.080 |
Why?
|
| Decision Making | 1 | 2017 | 977 | 0.080 |
Why?
|
| Biopsy | 3 | 2015 | 1082 | 0.080 |
Why?
|
| Gliadin | 1 | 2009 | 13 | 0.080 |
Why?
|
| Cholera Toxin | 1 | 2009 | 29 | 0.080 |
Why?
|
| Chromosomes, Human, Pair 1 | 3 | 2004 | 80 | 0.080 |
Why?
|
| Fetal Weight | 1 | 2009 | 53 | 0.070 |
Why?
|
| Synovitis | 1 | 2009 | 35 | 0.070 |
Why?
|
| Qualitative Research | 1 | 2017 | 1674 | 0.070 |
Why?
|
| Schizophrenia | 1 | 1993 | 453 | 0.070 |
Why?
|
| I-kappa B Proteins | 1 | 2009 | 75 | 0.070 |
Why?
|
| Nutrition Surveys | 3 | 2014 | 279 | 0.070 |
Why?
|
| Receptors, Somatostatin | 1 | 2009 | 24 | 0.070 |
Why?
|
| Immunization | 2 | 2022 | 375 | 0.070 |
Why?
|
| Haptoglobins | 1 | 2009 | 71 | 0.070 |
Why?
|
| Interferon-gamma | 1 | 2012 | 784 | 0.070 |
Why?
|
| Suppressor of Cytokine Signaling Proteins | 1 | 2008 | 20 | 0.070 |
Why?
|
| Intestinal Absorption | 1 | 2009 | 103 | 0.070 |
Why?
|
| Nutrition Assessment | 3 | 2017 | 90 | 0.070 |
Why?
|
| Protein Precursors | 1 | 2009 | 136 | 0.070 |
Why?
|
| Rheumatology | 1 | 2010 | 133 | 0.070 |
Why?
|
| 3-Oxo-5-alpha-Steroid 4-Dehydrogenase | 1 | 2008 | 7 | 0.070 |
Why?
|
| Decision Support Techniques | 1 | 2013 | 477 | 0.070 |
Why?
|
| Milk, Human | 1 | 2010 | 174 | 0.070 |
Why?
|
| Depression | 1 | 2018 | 1546 | 0.070 |
Why?
|
| Seasons | 4 | 2019 | 538 | 0.070 |
Why?
|
| Permeability | 1 | 2008 | 169 | 0.070 |
Why?
|
| Antigens, CD | 2 | 2009 | 558 | 0.070 |
Why?
|
| Pregnancy Trimester, Third | 2 | 2021 | 119 | 0.070 |
Why?
|
| Solanum tuberosum | 1 | 2008 | 8 | 0.070 |
Why?
|
| Organ Specificity | 2 | 2019 | 309 | 0.070 |
Why?
|
| Blotting, Western | 2 | 2001 | 1179 | 0.070 |
Why?
|
| Antirheumatic Agents | 2 | 2015 | 307 | 0.070 |
Why?
|
| Gastrointestinal Tract | 1 | 2010 | 204 | 0.070 |
Why?
|
| Influenza Vaccines | 1 | 2012 | 534 | 0.070 |
Why?
|
| TCF Transcription Factors | 1 | 2007 | 19 | 0.070 |
Why?
|
| HLA-DP Antigens | 1 | 2007 | 32 | 0.060 |
Why?
|
| gamma-Glutamyltransferase | 2 | 2019 | 42 | 0.060 |
Why?
|
| Seafood | 1 | 2007 | 25 | 0.060 |
Why?
|
| Creatinine | 2 | 2006 | 515 | 0.060 |
Why?
|
| Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha | 1 | 2007 | 39 | 0.060 |
Why?
|
| Aging | 3 | 2016 | 1969 | 0.060 |
Why?
|
| Genotyping Techniques | 2 | 2017 | 71 | 0.060 |
Why?
|
| Fluorescent Antibody Technique | 2 | 2020 | 365 | 0.060 |
Why?
|
| Rotavirus | 1 | 2006 | 21 | 0.060 |
Why?
|
| Plethysmography | 2 | 2017 | 104 | 0.060 |
Why?
|
| Diabetic Ketoacidosis | 1 | 2009 | 209 | 0.060 |
Why?
|
| Influenza, Human | 1 | 2012 | 624 | 0.060 |
Why?
|
| Hypoglycemic Agents | 2 | 2015 | 1399 | 0.060 |
Why?
|
| Rotavirus Infections | 1 | 2006 | 37 | 0.060 |
Why?
|
| Proteins | 2 | 2011 | 1023 | 0.060 |
Why?
|
| Glucose Intolerance | 2 | 2008 | 142 | 0.060 |
Why?
|
| Delivery, Obstetric | 2 | 2004 | 160 | 0.060 |
Why?
|
| Chromosomes, Human, Pair 11 | 1 | 2006 | 59 | 0.060 |
Why?
|
| Amino Acid Substitution | 1 | 2007 | 302 | 0.060 |
Why?
|
| Mutation | 1 | 2017 | 4075 | 0.060 |
Why?
|
| Health Behavior | 1 | 2012 | 789 | 0.060 |
Why?
|
| Pro-Opiomelanocortin | 1 | 2005 | 20 | 0.060 |
Why?
|
| Polymerase Chain Reaction | 4 | 2016 | 1041 | 0.060 |
Why?
|
| Weight Gain | 1 | 2009 | 561 | 0.060 |
Why?
|
| Trypsin Inhibitor, Kazal Pancreatic | 1 | 2005 | 6 | 0.060 |
Why?
|
| Gene Expression Regulation | 3 | 2016 | 2597 | 0.060 |
Why?
|
| Fibrinogen | 2 | 2019 | 180 | 0.060 |
Why?
|
| Receptors, Adrenergic, beta-2 | 1 | 2005 | 36 | 0.060 |
Why?
|
| Genome Components | 1 | 2005 | 2 | 0.060 |
Why?
|
| New South Wales | 1 | 2025 | 22 | 0.060 |
Why?
|
| Antibodies, Antinuclear | 2 | 2014 | 62 | 0.050 |
Why?
|
| Mendelian Randomization Analysis | 1 | 2025 | 55 | 0.050 |
Why?
|
| Paternal Age | 1 | 2024 | 3 | 0.050 |
Why?
|
| Lung Diseases | 1 | 2011 | 780 | 0.050 |
Why?
|
| Switzerland | 1 | 2025 | 46 | 0.050 |
Why?
|
| Codon | 1 | 2005 | 92 | 0.050 |
Why?
|
| gamma-Tocopherol | 1 | 2024 | 8 | 0.050 |
Why?
|
| Artificial Intelligence | 1 | 2010 | 381 | 0.050 |
Why?
|
| alpha-Tocopherol | 1 | 2024 | 32 | 0.050 |
Why?
|
| Kaplan-Meier Estimate | 2 | 2017 | 969 | 0.050 |
Why?
|
| Postpartum Period | 2 | 2021 | 373 | 0.050 |
Why?
|
| Receptors, CXCR5 | 1 | 2024 | 27 | 0.050 |
Why?
|
| Arthritis, Juvenile | 1 | 2005 | 60 | 0.050 |
Why?
|
| Albuminuria | 1 | 2005 | 189 | 0.050 |
Why?
|
| Gastrointestinal Diseases | 2 | 2019 | 221 | 0.050 |
Why?
|
| Intestine, Small | 1 | 2005 | 167 | 0.050 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 1 | 3 | 2004 | 44 | 0.050 |
Why?
|
| Phospholipases | 1 | 2023 | 14 | 0.050 |
Why?
|
| Embryonic and Fetal Development | 1 | 2003 | 93 | 0.050 |
Why?
|
| Sequence Analysis, DNA | 2 | 2017 | 777 | 0.050 |
Why?
|
| Radiography | 3 | 2013 | 852 | 0.050 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2005 | 376 | 0.050 |
Why?
|
| Reference Values | 3 | 1999 | 798 | 0.050 |
Why?
|
| Iron, Dietary | 1 | 2023 | 23 | 0.050 |
Why?
|
| Pulmonary Fibrosis | 1 | 2007 | 395 | 0.050 |
Why?
|
| Glutamates | 1 | 2023 | 66 | 0.050 |
Why?
|
| Prevotella | 1 | 2023 | 26 | 0.050 |
Why?
|
| Transforming Growth Factor beta | 2 | 2022 | 474 | 0.050 |
Why?
|
| Urban Health | 2 | 2006 | 96 | 0.050 |
Why?
|
| Anti-Bacterial Agents | 2 | 2011 | 1923 | 0.050 |
Why?
|
| Protein Tyrosine Phosphatases | 3 | 2004 | 167 | 0.050 |
Why?
|
| Abdomen | 1 | 2003 | 142 | 0.050 |
Why?
|
| Income | 1 | 2003 | 202 | 0.050 |
Why?
|
| Immunoglobulin Isotypes | 1 | 2022 | 36 | 0.050 |
Why?
|
| Social Determinants of Health | 1 | 2026 | 308 | 0.040 |
Why?
|
| Nitrates | 1 | 1992 | 93 | 0.040 |
Why?
|
| Water Supply | 1 | 1992 | 89 | 0.040 |
Why?
|
| Sequence Homology, Amino Acid | 2 | 2000 | 387 | 0.040 |
Why?
|
| Physical Chromosome Mapping | 1 | 2021 | 21 | 0.040 |
Why?
|
| Occult Blood | 1 | 2001 | 40 | 0.040 |
Why?
|
| Epidemiologic Studies | 1 | 2021 | 68 | 0.040 |
Why?
|
| Selection Bias | 1 | 2021 | 38 | 0.040 |
Why?
|
| Rats | 5 | 2025 | 5584 | 0.040 |
Why?
|
| Treatment Outcome | 4 | 2004 | 11772 | 0.040 |
Why?
|
| Immunization Schedule | 1 | 2022 | 186 | 0.040 |
Why?
|
| Diagnostic Techniques, Radioisotope | 1 | 2021 | 9 | 0.040 |
Why?
|
| Immunoglobulin D | 1 | 2021 | 29 | 0.040 |
Why?
|
| Pseudomonas Infections | 1 | 2003 | 230 | 0.040 |
Why?
|
| Serologic Tests | 1 | 2021 | 54 | 0.040 |
Why?
|
| Fimbriae, Bacterial | 1 | 2001 | 36 | 0.040 |
Why?
|
| Ciprofloxacin | 2 | 2011 | 31 | 0.040 |
Why?
|
| Prostatic Neoplasms | 1 | 2008 | 978 | 0.040 |
Why?
|
| Waist Circumference | 2 | 2013 | 143 | 0.040 |
Why?
|
| Electrochemical Techniques | 1 | 2021 | 55 | 0.040 |
Why?
|
| Probability | 1 | 2021 | 307 | 0.040 |
Why?
|
| Financial Management | 1 | 2020 | 16 | 0.040 |
Why?
|
| Interleukin-10 | 1 | 2022 | 309 | 0.040 |
Why?
|
| Asymptomatic Diseases | 1 | 2021 | 104 | 0.040 |
Why?
|
| Sequence Analysis, Protein | 1 | 2000 | 32 | 0.040 |
Why?
|
| Synovial Fluid | 1 | 2020 | 67 | 0.040 |
Why?
|
| Databases, Genetic | 1 | 2021 | 238 | 0.040 |
Why?
|
| Flow Cytometry | 1 | 2024 | 1162 | 0.040 |
Why?
|
| Kidney Failure, Chronic | 1 | 2006 | 599 | 0.040 |
Why?
|
| Collagenases | 1 | 2000 | 22 | 0.040 |
Why?
|
| Mannose | 1 | 2019 | 23 | 0.040 |
Why?
|
| Glucose Transporter Type 2 | 1 | 2019 | 16 | 0.040 |
Why?
|
| Laryngitis | 1 | 2019 | 3 | 0.040 |
Why?
|
| Multifactorial Inheritance | 1 | 2021 | 195 | 0.040 |
Why?
|
| Norway | 1 | 2019 | 41 | 0.040 |
Why?
|
| Adenosine Diphosphate | 1 | 2019 | 83 | 0.040 |
Why?
|
| Sequence Homology | 1 | 1999 | 43 | 0.040 |
Why?
|
| Gene Library | 1 | 2000 | 122 | 0.040 |
Why?
|
| Immunoglobulin Variable Region | 2 | 1996 | 80 | 0.040 |
Why?
|
| Sequence Alignment | 1 | 2000 | 362 | 0.040 |
Why?
|
| Conjunctivitis | 1 | 2019 | 30 | 0.040 |
Why?
|
| Bicuspid | 1 | 1999 | 14 | 0.040 |
Why?
|
| Cuspid | 1 | 1999 | 9 | 0.040 |
Why?
|
| Microbial Sensitivity Tests | 2 | 2011 | 364 | 0.040 |
Why?
|
| Periodontal Index | 1 | 1999 | 14 | 0.040 |
Why?
|
| DNA Probes | 1 | 1999 | 59 | 0.040 |
Why?
|
| Blotting, Southern | 1 | 1999 | 85 | 0.040 |
Why?
|
| Residence Characteristics | 2 | 2019 | 375 | 0.040 |
Why?
|
| Health Plan Implementation | 1 | 2020 | 141 | 0.040 |
Why?
|
| Immunoglobulin E | 1 | 2021 | 315 | 0.040 |
Why?
|
| Colony Count, Microbial | 1 | 1999 | 89 | 0.040 |
Why?
|
| LIM-Homeodomain Proteins | 1 | 2019 | 16 | 0.040 |
Why?
|
| Pregnancy Complications, Infectious | 1 | 2003 | 440 | 0.040 |
Why?
|
| Maternal Behavior | 1 | 1999 | 84 | 0.040 |
Why?
|
| Butyrates | 1 | 2019 | 66 | 0.040 |
Why?
|
| Energy Metabolism | 2 | 2018 | 935 | 0.040 |
Why?
|
| Methotrexate | 1 | 2020 | 233 | 0.040 |
Why?
|
| Antibodies, Monoclonal | 2 | 1996 | 1505 | 0.040 |
Why?
|
| Calibration | 1 | 1999 | 152 | 0.040 |
Why?
|
| Epidemiologic Methods | 2 | 2013 | 91 | 0.040 |
Why?
|
| Reference Standards | 1 | 1999 | 177 | 0.040 |
Why?
|
| Lung | 3 | 2017 | 4106 | 0.040 |
Why?
|
| Brazil | 1 | 2019 | 179 | 0.030 |
Why?
|
| Powders | 1 | 2018 | 44 | 0.030 |
Why?
|
| Health Services | 1 | 1999 | 113 | 0.030 |
Why?
|
| Small-Area Analysis | 1 | 1997 | 6 | 0.030 |
Why?
|
| Proteomics | 1 | 2025 | 1188 | 0.030 |
Why?
|
| Outpatients | 1 | 1992 | 447 | 0.030 |
Why?
|
| Abortion, Spontaneous | 1 | 1999 | 118 | 0.030 |
Why?
|
| Fever | 1 | 2019 | 319 | 0.030 |
Why?
|
| Health Equity | 1 | 2020 | 133 | 0.030 |
Why?
|
| Military Personnel | 1 | 2025 | 737 | 0.030 |
Why?
|
| Community Health Planning | 1 | 1997 | 36 | 0.030 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2019 | 194 | 0.030 |
Why?
|
| Multiple Organ Failure | 1 | 1998 | 120 | 0.030 |
Why?
|
| Diastole | 1 | 2018 | 146 | 0.030 |
Why?
|
| DNA, Bacterial | 1 | 1999 | 320 | 0.030 |
Why?
|
| Forecasting | 1 | 2019 | 390 | 0.030 |
Why?
|
| Systole | 1 | 2018 | 181 | 0.030 |
Why?
|
| Discriminant Analysis | 1 | 2017 | 35 | 0.030 |
Why?
|
| Whooping Cough | 1 | 1997 | 55 | 0.030 |
Why?
|
| Health Planning | 1 | 1997 | 47 | 0.030 |
Why?
|
| Calcium-Binding Proteins | 1 | 2019 | 221 | 0.030 |
Why?
|
| Abdominal Neoplasms | 1 | 1977 | 47 | 0.030 |
Why?
|
| Multiple Trauma | 1 | 1998 | 121 | 0.030 |
Why?
|
| Titanium | 1 | 1977 | 74 | 0.030 |
Why?
|
| Blood Group Antigens | 1 | 1997 | 15 | 0.030 |
Why?
|
| Muscle Proteins | 1 | 2019 | 242 | 0.030 |
Why?
|
| Molecular Weight | 1 | 2017 | 312 | 0.030 |
Why?
|
| Double-Blind Method | 2 | 2004 | 2062 | 0.030 |
Why?
|
| Genes, Immunoglobulin Light Chain | 1 | 2016 | 4 | 0.030 |
Why?
|
| Genes, Immunoglobulin Heavy Chain | 1 | 2016 | 10 | 0.030 |
Why?
|
| Phosphofructokinase-2 | 1 | 2016 | 16 | 0.030 |
Why?
|
| Cholesterol | 1 | 2019 | 408 | 0.030 |
Why?
|
| Diabetes Complications | 1 | 2018 | 224 | 0.030 |
Why?
|
| Otitis Media | 1 | 2019 | 182 | 0.030 |
Why?
|
| Glomerular Mesangium | 1 | 1996 | 21 | 0.030 |
Why?
|
| CTLA-4 Antigen | 2 | 2009 | 105 | 0.030 |
Why?
|
| Antibody Formation | 1 | 2018 | 288 | 0.030 |
Why?
|
| Data Collection | 1 | 2019 | 640 | 0.030 |
Why?
|
| Ataxia Telangiectasia Mutated Proteins | 1 | 2016 | 69 | 0.030 |
Why?
|
| Hospitalization | 2 | 2004 | 2460 | 0.030 |
Why?
|
| Endpoint Determination | 1 | 2017 | 85 | 0.030 |
Why?
|
| Recombinant Proteins | 1 | 2000 | 1368 | 0.030 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 1997 | 147 | 0.030 |
Why?
|
| Acute Disease | 1 | 2019 | 1036 | 0.030 |
Why?
|
| Sirtuin 1 | 1 | 2016 | 34 | 0.030 |
Why?
|
| Evidence-Based Medicine | 1 | 2020 | 740 | 0.030 |
Why?
|
| Models, Biological | 2 | 2019 | 1764 | 0.030 |
Why?
|
| Enterovirus | 1 | 1997 | 83 | 0.030 |
Why?
|
| Los Angeles | 2 | 2008 | 73 | 0.030 |
Why?
|
| Pilot Projects | 1 | 2002 | 1891 | 0.030 |
Why?
|
| Complement Activation | 1 | 2019 | 399 | 0.030 |
Why?
|
| Electrodes | 1 | 1996 | 111 | 0.030 |
Why?
|
| Protein Isoforms | 1 | 2017 | 397 | 0.030 |
Why?
|
| Bromobenzenes | 1 | 1975 | 1 | 0.030 |
Why?
|
| Phenyl Ethers | 1 | 1975 | 5 | 0.030 |
Why?
|
| DNA, Mitochondrial | 1 | 1997 | 211 | 0.030 |
Why?
|
| Infant Mortality | 1 | 1996 | 128 | 0.030 |
Why?
|
| Escherichia coli | 1 | 2000 | 835 | 0.030 |
Why?
|
| Disease-Free Survival | 1 | 2017 | 767 | 0.030 |
Why?
|
| Mortality | 2 | 2007 | 378 | 0.030 |
Why?
|
| Fragile X Syndrome | 1 | 1996 | 119 | 0.030 |
Why?
|
| Georgia | 1 | 2015 | 79 | 0.030 |
Why?
|
| Patient-Centered Care | 1 | 2020 | 547 | 0.030 |
Why?
|
| Functional Laterality | 1 | 1996 | 240 | 0.030 |
Why?
|
| Symptom Assessment | 1 | 2016 | 136 | 0.030 |
Why?
|
| Glucose-6-Phosphatase | 1 | 2015 | 32 | 0.030 |
Why?
|
| Florida | 1 | 2015 | 117 | 0.030 |
Why?
|
| Erythrocyte Count | 1 | 2014 | 21 | 0.030 |
Why?
|
| Blood Proteins | 1 | 1997 | 239 | 0.030 |
Why?
|
| Biphenyl Compounds | 1 | 1975 | 67 | 0.030 |
Why?
|
| Washington | 1 | 2015 | 149 | 0.030 |
Why?
|
| North America | 1 | 1996 | 302 | 0.030 |
Why?
|
| Base Sequence | 3 | 2010 | 2170 | 0.030 |
Why?
|
| Solubility | 1 | 2015 | 240 | 0.030 |
Why?
|
| Databases, Nucleic Acid | 1 | 2014 | 38 | 0.030 |
Why?
|
| Alzheimer Disease | 1 | 2021 | 630 | 0.030 |
Why?
|
| Hematocrit | 1 | 2014 | 108 | 0.030 |
Why?
|
| Neurology | 1 | 1996 | 116 | 0.030 |
Why?
|
| Cross-Cultural Comparison | 1 | 2015 | 84 | 0.030 |
Why?
|
| Isoenzymes | 2 | 2006 | 294 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2015 | 2028 | 0.030 |
Why?
|
| Rituximab | 1 | 2015 | 210 | 0.030 |
Why?
|
| Datasets as Topic | 1 | 2014 | 118 | 0.030 |
Why?
|
| Glucagon-Like Peptide-1 Receptor | 1 | 2015 | 88 | 0.030 |
Why?
|
| Synovial Membrane | 1 | 2015 | 123 | 0.030 |
Why?
|
| Cholesterol Ester Transfer Proteins | 1 | 2014 | 22 | 0.030 |
Why?
|
| Apolipoproteins | 1 | 2014 | 38 | 0.030 |
Why?
|
| Gene Expression Profiling | 1 | 2021 | 1767 | 0.030 |
Why?
|
| Leukocyte Count | 1 | 2014 | 316 | 0.030 |
Why?
|
| Patient Safety | 1 | 2017 | 356 | 0.030 |
Why?
|
| Birth Order | 2 | 2004 | 14 | 0.030 |
Why?
|
| Neurocan | 1 | 2013 | 1 | 0.020 |
Why?
|
| Family Characteristics | 1 | 2015 | 195 | 0.020 |
Why?
|
| Chondroitin Sulfate Proteoglycans | 1 | 2013 | 10 | 0.020 |
Why?
|
| Histocompatibility Antigens Class II | 2 | 2008 | 364 | 0.020 |
Why?
|
| Biomedical Research | 1 | 2020 | 717 | 0.020 |
Why?
|
| Lipoproteins, HDL | 1 | 2014 | 100 | 0.020 |
Why?
|
| Lysophospholipase | 1 | 2013 | 10 | 0.020 |
Why?
|
| Plant Roots | 1 | 2013 | 37 | 0.020 |
Why?
|
| Glucose Clamp Technique | 1 | 2014 | 199 | 0.020 |
Why?
|
| Lectins, C-Type | 1 | 2013 | 59 | 0.020 |
Why?
|
| Amino Acids, Branched-Chain | 1 | 2013 | 39 | 0.020 |
Why?
|
| Phosphoprotein Phosphatases | 1 | 2013 | 66 | 0.020 |
Why?
|
| Colorectal Neoplasms | 1 | 2001 | 866 | 0.020 |
Why?
|
| Attitude to Health | 1 | 1996 | 430 | 0.020 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2016 | 530 | 0.020 |
Why?
|
| Brain Ischemia | 1 | 1997 | 359 | 0.020 |
Why?
|
| Nervous System Diseases | 1 | 1996 | 286 | 0.020 |
Why?
|
| Fetal Development | 1 | 2016 | 298 | 0.020 |
Why?
|
| HLA-DR2 Antigen | 1 | 2012 | 8 | 0.020 |
Why?
|
| Cystic Fibrosis | 1 | 2003 | 1161 | 0.020 |
Why?
|
| Culture | 1 | 2013 | 124 | 0.020 |
Why?
|
| Promoter Regions, Genetic | 2 | 2009 | 1246 | 0.020 |
Why?
|
| Fruit | 1 | 2013 | 146 | 0.020 |
Why?
|
| Vaccines, Inactivated | 1 | 2012 | 70 | 0.020 |
Why?
|
| Health Surveys | 2 | 2010 | 518 | 0.020 |
Why?
|
| Intestines | 1 | 2015 | 354 | 0.020 |
Why?
|
| Dose-Response Relationship, Immunologic | 1 | 2012 | 76 | 0.020 |
Why?
|
| Evoked Potentials | 1 | 1993 | 131 | 0.020 |
Why?
|
| Ireland | 1 | 2012 | 32 | 0.020 |
Why?
|
| Frontal Lobe | 1 | 1993 | 160 | 0.020 |
Why?
|
| Antigens | 1 | 1994 | 348 | 0.020 |
Why?
|
| Genome | 1 | 2014 | 305 | 0.020 |
Why?
|
| Public Health | 1 | 2017 | 572 | 0.020 |
Why?
|
| Tuberculin Test | 1 | 2012 | 36 | 0.020 |
Why?
|
| Sentinel Surveillance | 1 | 2012 | 46 | 0.020 |
Why?
|
| Hemoglobins | 1 | 2014 | 386 | 0.020 |
Why?
|
| Arthrography | 1 | 2011 | 19 | 0.020 |
Why?
|
| Solvents | 1 | 2012 | 112 | 0.020 |
Why?
|
| Models, Statistical | 2 | 2009 | 671 | 0.020 |
Why?
|
| Indians, North American | 1 | 1997 | 597 | 0.020 |
Why?
|
| Receptor, Melanocortin, Type 4 | 1 | 2011 | 17 | 0.020 |
Why?
|
| Academic Medical Centers | 1 | 1994 | 554 | 0.020 |
Why?
|
| Anxiety Disorders | 1 | 1994 | 369 | 0.020 |
Why?
|
| Cell Adhesion Molecules, Neuronal | 1 | 2011 | 42 | 0.020 |
Why?
|
| GPI-Linked Proteins | 1 | 2011 | 81 | 0.020 |
Why?
|
| ROC Curve | 1 | 2013 | 617 | 0.020 |
Why?
|
| Communication | 1 | 2017 | 975 | 0.020 |
Why?
|
| Silicon Dioxide | 1 | 2012 | 119 | 0.020 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2020 | 1371 | 0.020 |
Why?
|
| Leptin | 1 | 2012 | 248 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2015 | 1111 | 0.020 |
Why?
|
| Congresses as Topic | 1 | 2012 | 223 | 0.020 |
Why?
|
| Women's Health | 1 | 2013 | 314 | 0.020 |
Why?
|
| Aza Compounds | 1 | 2010 | 12 | 0.020 |
Why?
|
| Child Abuse | 1 | 1996 | 552 | 0.020 |
Why?
|
| Diabetic Angiopathies | 1 | 2012 | 264 | 0.020 |
Why?
|
| NF-KappaB Inhibitor alpha | 1 | 2009 | 50 | 0.020 |
Why?
|
| Obesity, Abdominal | 1 | 2010 | 47 | 0.020 |
Why?
|
| Sample Size | 1 | 2010 | 121 | 0.020 |
Why?
|
| Space-Time Clustering | 1 | 1989 | 3 | 0.020 |
Why?
|
| Actuarial Analysis | 1 | 1989 | 16 | 0.020 |
Why?
|
| Ultraviolet Rays | 1 | 2012 | 384 | 0.020 |
Why?
|
| Blood Glucose Self-Monitoring | 1 | 2015 | 701 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 2 | 1 | 2009 | 28 | 0.020 |
Why?
|
| Diarrhea | 1 | 2010 | 193 | 0.020 |
Why?
|
| Community-Institutional Relations | 1 | 2009 | 100 | 0.020 |
Why?
|
| Suppressor of Cytokine Signaling 3 Protein | 1 | 2008 | 11 | 0.020 |
Why?
|
| Disease | 1 | 2010 | 96 | 0.020 |
Why?
|
| Southwestern United States | 1 | 2009 | 93 | 0.020 |
Why?
|
| Maternal Exposure | 1 | 2011 | 189 | 0.020 |
Why?
|
| Body Weights and Measures | 1 | 2008 | 37 | 0.020 |
Why?
|
| Quinolines | 1 | 2010 | 190 | 0.020 |
Why?
|
| Genetic Carrier Screening | 1 | 2008 | 32 | 0.020 |
Why?
|
| Medical Records | 2 | 1999 | 192 | 0.020 |
Why?
|
| Wounds and Injuries | 1 | 1996 | 961 | 0.020 |
Why?
|
| Coxsackievirus Infections | 1 | 1987 | 14 | 0.020 |
Why?
|
| Sleep Deprivation | 1 | 2010 | 206 | 0.020 |
Why?
|
| Genetic Counseling | 2 | 1999 | 80 | 0.020 |
Why?
|
| Health Services Accessibility | 1 | 1996 | 1101 | 0.020 |
Why?
|
| Age Distribution | 2 | 1999 | 403 | 0.020 |
Why?
|
| Survival | 1 | 2007 | 38 | 0.020 |
Why?
|
| Sex Distribution | 1 | 2008 | 387 | 0.020 |
Why?
|
| Spleen | 1 | 2009 | 508 | 0.020 |
Why?
|
| HLA-DP beta-Chains | 1 | 2007 | 88 | 0.020 |
Why?
|
| Cause of Death | 1 | 1989 | 470 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 6 | 1 | 2006 | 46 | 0.020 |
Why?
|
| RNA, Viral | 1 | 2010 | 692 | 0.020 |
Why?
|
| Recurrence | 1 | 2010 | 1138 | 0.010 |
Why?
|
| Breeding | 1 | 2006 | 63 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2017 | 5983 | 0.010 |
Why?
|
| Urban Population | 1 | 2009 | 493 | 0.010 |
Why?
|
| Receptors, Interleukin-4 | 1 | 2005 | 16 | 0.010 |
Why?
|
| Subcutaneous Fat, Abdominal | 1 | 2005 | 15 | 0.010 |
Why?
|
| Rural Health | 1 | 2006 | 87 | 0.010 |
Why?
|
| Antigens, Differentiation | 1 | 2005 | 76 | 0.010 |
Why?
|
| Gene Expression | 1 | 2010 | 1476 | 0.010 |
Why?
|
| Emergency Service, Hospital | 1 | 2017 | 2381 | 0.010 |
Why?
|
| Albumins | 1 | 2005 | 119 | 0.010 |
Why?
|
| Interleukin-4 | 1 | 2005 | 207 | 0.010 |
Why?
|
| Interleukin-13 | 1 | 2005 | 146 | 0.010 |
Why?
|
| Open Reading Frames | 1 | 2005 | 130 | 0.010 |
Why?
|
| 3' Untranslated Regions | 1 | 2005 | 149 | 0.010 |
Why?
|
| Models, Theoretical | 1 | 2008 | 558 | 0.010 |
Why?
|
| Motor Activity | 1 | 2009 | 718 | 0.010 |
Why?
|
| False Positive Reactions | 1 | 2004 | 123 | 0.010 |
Why?
|
| Growth | 1 | 2004 | 49 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 13 | 1 | 2003 | 15 | 0.010 |
Why?
|
| Rural Population | 1 | 2009 | 659 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 5 | 1 | 2003 | 28 | 0.010 |
Why?
|
| Pancreatitis | 1 | 2005 | 146 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 19 | 1 | 2003 | 27 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 16 | 1 | 2003 | 36 | 0.010 |
Why?
|
| Radioimmunoassay | 1 | 2004 | 165 | 0.010 |
Why?
|
| Adult Children | 1 | 2003 | 27 | 0.010 |
Why?
|
| Primary Health Care | 1 | 1994 | 1735 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 8 | 1 | 2003 | 38 | 0.010 |
Why?
|
| Confidence Intervals | 1 | 2004 | 330 | 0.010 |
Why?
|
| Single-Blind Method | 1 | 2004 | 318 | 0.010 |
Why?
|
| Medicaid | 2 | 1999 | 467 | 0.010 |
Why?
|
| Genetics, Population | 1 | 2004 | 217 | 0.010 |
Why?
|
| Remission Induction | 1 | 2004 | 307 | 0.010 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2004 | 177 | 0.010 |
Why?
|
| Monte Carlo Method | 1 | 2003 | 147 | 0.010 |
Why?
|
| Causality | 1 | 2003 | 126 | 0.010 |
Why?
|
| HLA-A Antigens | 1 | 2002 | 52 | 0.010 |
Why?
|
| Survival Rate | 1 | 2006 | 2090 | 0.010 |
Why?
|
| Morbidity | 1 | 1992 | 322 | 0.010 |
Why?
|
| Neonatal Screening | 1 | 2003 | 179 | 0.010 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 2002 | 202 | 0.010 |
Why?
|
| United Kingdom | 1 | 2001 | 344 | 0.010 |
Why?
|
| Pseudomonas aeruginosa | 1 | 2003 | 395 | 0.010 |
Why?
|
| Haemophilus influenzae type b | 1 | 1999 | 12 | 0.010 |
Why?
|
| Diphtheria-Tetanus-Pertussis Vaccine | 1 | 1999 | 28 | 0.010 |
Why?
|
| Haemophilus Vaccines | 1 | 1999 | 29 | 0.010 |
Why?
|
| Poliovirus Vaccine, Inactivated | 1 | 1999 | 27 | 0.010 |
Why?
|
| Capitation Fee | 1 | 1999 | 14 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2010 | 4560 | 0.010 |
Why?
|
| Hepatitis B Vaccines | 1 | 1999 | 43 | 0.010 |
Why?
|
| Chronic Disease | 1 | 2005 | 1808 | 0.010 |
Why?
|
| Office Visits | 1 | 1999 | 92 | 0.010 |
Why?
|
| Colonoscopy | 1 | 2001 | 263 | 0.010 |
Why?
|
| Fee-for-Service Plans | 1 | 1999 | 99 | 0.010 |
Why?
|
| Pennsylvania | 1 | 1999 | 138 | 0.010 |
Why?
|
| Platelet Count | 1 | 1998 | 94 | 0.010 |
Why?
|
| APACHE | 1 | 1998 | 68 | 0.010 |
Why?
|
| Acne Vulgaris | 2 | 1975 | 25 | 0.010 |
Why?
|
| Abnormalities, Drug-Induced | 2 | 1975 | 38 | 0.010 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2004 | 1747 | 0.010 |
Why?
|
| Lymphocyte Count | 1 | 1998 | 164 | 0.010 |
Why?
|
| CD4 Lymphocyte Count | 1 | 1998 | 280 | 0.010 |
Why?
|
| Asbestos | 1 | 1977 | 36 | 0.010 |
Why?
|
| Population Density | 1 | 1997 | 89 | 0.010 |
Why?
|
| Demography | 1 | 1998 | 282 | 0.010 |
Why?
|
| Coronary Artery Disease | 1 | 2004 | 749 | 0.010 |
Why?
|
| Cricetinae | 1 | 1977 | 305 | 0.010 |
Why?
|
| Polymorphism, Restriction Fragment Length | 1 | 1997 | 60 | 0.010 |
Why?
|
| Fluid Therapy | 1 | 1998 | 155 | 0.010 |
Why?
|
| Rabbits | 2 | 1975 | 652 | 0.010 |
Why?
|
| Marital Status | 1 | 1996 | 46 | 0.010 |
Why?
|
| Rats, Inbred BB | 1 | 1996 | 5 | 0.010 |
Why?
|
| Information Systems | 1 | 1996 | 56 | 0.010 |
Why?
|
| Receptors, Antigen, T-Cell, alpha-beta | 1 | 1998 | 334 | 0.010 |
Why?
|
| Genes, Immunoglobulin | 1 | 1996 | 29 | 0.010 |
Why?
|
| Japan | 1 | 1996 | 149 | 0.010 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 1996 | 157 | 0.010 |
Why?
|
| Injury Severity Score | 1 | 1998 | 599 | 0.010 |
Why?
|
| Quality Control | 1 | 1996 | 161 | 0.010 |
Why?
|
| Bacterial Infections | 1 | 1998 | 246 | 0.010 |
Why?
|
| Prejudice | 1 | 1996 | 60 | 0.010 |
Why?
|
| Hybridomas | 1 | 1996 | 233 | 0.010 |
Why?
|
| T-Lymphocyte Subsets | 1 | 1998 | 418 | 0.010 |
Why?
|
| Bronchi | 1 | 1977 | 263 | 0.010 |
Why?
|
| Lupus Nephritis | 1 | 1996 | 67 | 0.010 |
Why?
|
| Virus Diseases | 1 | 1998 | 216 | 0.010 |
Why?
|
| Mice, Mutant Strains | 1 | 1996 | 302 | 0.010 |
Why?
|
| Marriage | 1 | 1997 | 121 | 0.010 |
Why?
|
| Polybrominated Biphenyls | 1 | 1975 | 2 | 0.010 |
Why?
|
| Bromine | 1 | 1975 | 5 | 0.010 |
Why?
|
| Halogenated Diphenyl Ethers | 1 | 1975 | 7 | 0.010 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 1996 | 376 | 0.010 |
Why?
|
| Microscopy, Electron | 1 | 1996 | 414 | 0.010 |
Why?
|
| Chemistry | 1 | 1975 | 40 | 0.010 |
Why?
|
| Chemical Phenomena | 1 | 1975 | 77 | 0.010 |
Why?
|
| Erythema | 1 | 1975 | 28 | 0.010 |
Why?
|
| Cloning, Molecular | 1 | 1996 | 538 | 0.010 |
Why?
|
| Blood Transfusion | 1 | 1998 | 409 | 0.010 |
Why?
|
| Lymph Nodes | 1 | 1977 | 503 | 0.010 |
Why?
|
| Intubation, Gastrointestinal | 1 | 1975 | 81 | 0.010 |
Why?
|
| Eye | 1 | 1975 | 112 | 0.010 |
Why?
|
| Viral Proteins | 1 | 1997 | 350 | 0.010 |
Why?
|
| Ligands | 1 | 1996 | 665 | 0.010 |
Why?
|
| Dioxins | 1 | 1973 | 7 | 0.010 |
Why?
|
| Poverty | 1 | 1997 | 526 | 0.010 |
Why?
|
| Reproduction | 1 | 1975 | 208 | 0.010 |
Why?
|
| Neoplasms | 1 | 1989 | 2906 | 0.010 |
Why?
|
| Skinfold Thickness | 1 | 1992 | 43 | 0.010 |
Why?
|
| Sex Characteristics | 1 | 1998 | 782 | 0.010 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 1994 | 531 | 0.010 |
Why?
|
| Emergency Medical Services | 1 | 1999 | 684 | 0.010 |
Why?
|
| Models, Molecular | 1 | 1996 | 1598 | 0.010 |
Why?
|
| Patient Discharge | 1 | 1997 | 992 | 0.010 |
Why?
|
| Fetus | 1 | 1975 | 804 | 0.010 |
Why?
|
| Medicare | 1 | 1996 | 903 | 0.000 |
Why?
|
| Macrophages | 1 | 1977 | 1507 | 0.000 |
Why?
|
| Kidney | 1 | 1996 | 1497 | 0.000 |
Why?
|
| Lethal Dose 50 | 1 | 1973 | 17 | 0.000 |
Why?
|
| Chlorobenzenes | 1 | 1973 | 18 | 0.000 |
Why?
|
| Injections, Intraperitoneal | 1 | 1973 | 116 | 0.000 |
Why?
|
| Guinea Pigs | 1 | 1973 | 159 | 0.000 |
Why?
|
| Chickens | 1 | 1973 | 179 | 0.000 |
Why?
|
| Edema | 1 | 1973 | 125 | 0.000 |
Why?
|
| Eye Diseases | 1 | 1973 | 97 | 0.000 |
Why?
|
| Chemical and Drug Induced Liver Injury | 1 | 1973 | 138 | 0.000 |
Why?
|
| Fetal Diseases | 1 | 1973 | 194 | 0.000 |
Why?
|
| Administration, Oral | 1 | 1973 | 866 | 0.000 |
Why?
|